Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Painkilling black mamba snake
Image: George Grall
Deadly snake venom could form strong painkiller

According to a study by french scientists, the venom of the black mamba snake could help to form a painkiller as powerful as morphine.

The black mamba snake, which derives from Africa, is one of the world's fastest and most venomous. It is a compound found in their venom, called mambalgins, which gives pain relief when isolated.

The mambalgins are expected to have no side effects in humans, making it a potential replacement for morphine, which is addictive and can cause headaches, vomiting and muscle-twitching, amongst other conditions.

The study was published in the Nature journal, following tests on mice that showed mambalgins block the central and peripheral nervous system's acid-sensing ion channels (ASICs), effectively giving pain relief.

Herpetologist and toxicologist, Zolan Takacs, said: "Animal venom toxins have a solid success rate [becoming] major drugs. There is no question this will continue, as the vast majority of toxins remain unexplored."

Study leader, Anne Baron, of the Institute of Molecular and Cellular Pharmacology in France, said: "It's remarkable that this was made possible from the deadly venom of one of the most venomous snakes."

However, Takacs added: "To develop a new drug you need 10 to 15 years hundreds of millions of dollars, and you still have no guarantees". 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk